FGF21 and Parkinson disease: Based on these findings, this suggests that Fibroblast growth factor 21 levels may serve as a mediator in the pathway linking Phosphatidylcholine (14:0_18:2) levels and PD, with a mediation effect of −0.024 and total effect of −0.131, the mediation effect accounts for approximately 18% of the total effect.